Science & Innovation Forum - Stop The Bleeding Fast: What’s New in Viscoelastic Testing

Please note: AABB reserves the right to make updates to this program.

Thursday, August 15, 2024
2:00 – 3:00 PM (ET)

Presented by HemoSonics, LLC, an AABB Premium Corporate Partner

HemosonicsJoin us for a 60-minute mini-symposium which will review key concepts in blood stewardship and optimized bleeding management.

With the advent of cartridge-based whole blood viscoelastic testing (VET) systems, limitations from legacy VET technologies, and challenges of conventional laboratory coagulation tests for acute bleeding management have been overcome. During this program, you will learn how an optimized VET platform can help providers deliver timely hemostasis, while conserving blood, reducing costs, and improving outcomes in critical bleeding situations. In addition, faculty will highlight the transition from empirical decision making in bleeding situations to a Goal-Directed Therapeutic (GDT) approach. This includes presenting guidelines and data that demonstrate improvements in clinical outcomes, costs, and healthcare efficiencies achieved through the functional implementation of a viscoelastic-guided technique.

The program will outline a practical, multi-disciplinary approach to evaluating and updating bleeding management practices, with an emphasis on implementation of advanced processes and technologies. Real-world applications of biotherapeutic and blood component decision-making using viscoelastic testing (e.g., Quantra®, ROTEM®, TEG®), illustrating the efficient use of and avoidance of unnecessary therapies will be shared. This program is an excellent opportunity to learn about the latest advancements in optimizing care for bleeding patients.

A live Q&A session will follow to address questions and provide further insights.

After attending this program, participants should be able to:

  • Review the challenges associated with traditional viscoelastic and conventional laboratory-based coagulation tests.
  • Describe the technological advancements and define the steps to assess the new systems.
  • Explain the multidisciplinary implementation process to optimize the benefits of Goal-Directed transfusions.
  • Describe how Goal-Directed Therapy (GDT) helps providers quickly manage acute bleeding, conserve blood products, and improve outcomes.
  • Discuss the real-world application of VET-guided blood components and biotherapies.
  • Intended Audience: Directors, Hospital Blood Banks, Hospitals, Immunohematology Reference Labs (IRL’s), Laboratory Staff, Managers/Supervisors, Medical Directors, Nurses, Perfusionists, Physicians, Research Scientists, Residents/Fellows, Scientists, Students (MD, MT, SBB), Technologists, Transfusion Safety Officers
  • Registration

    This Science & Innovation Forum is complimentary to all, but registration is required. By registering for this AABB-hosted program you consent to have your information shared with the sponsoring organization, HemoSonics, LLC. Register here.


    Moderator: Joseph R. Griggs, DO, Associate Professor, UNM Department of Pathology; Medical Director, Transfusion Service; Director of Blood Bank/Transfusion Medicine Fellowship; Associate Director Pathology Residency Program, University of New Mexico Hospital


    Jonathan H. Chow, MDJonathan H. Chow, MD
    Associate Professor
    Chief, Liver Transplant Anesthesiology
    Department of Anesthesiology and Critical Care Medicine
    George Washington University School of Medicine

    Joseph R. Griggs, DOJoseph R. Griggs, DO
    Associate Professor, UNM Department of Pathology
    Medical Director, Transfusion Service
    Director of Blood Bank/Transfusion Medicine Fellowship
    Associate Director Pathology Residency Program
    University of New Mexico Hospital

    Michael Mazzeffi, MD, MPH, FASAMichael Mazzeffi, MD, MPH, FASA
    Vice Chair of Faculty Affairs & Development; Anesthesiology
    University of Virginia School of Medicine

    The content of this event was developed independently from the AABB continuing education program. The opinions expressed are those of the faculty. Continuing education credit is not offered.

    Science & Innovation Forums are live and on-demand programs that are presented by companies serving the AABB community and target critical needs in the field that can be addressed by the sponsor’s solutions technology. Registration is complimentary to all.